Skip to main content
European Commission logo print header

circular RNA Biology Training Network: from biogenesis to biomarkers

Description du projet

Une vision globale des ARN circulaires

Les ARN circulaires sont des molécules d’ARN fermées à un seul brin qui sont omniprésentes dans toutes les espèces, des virus aux mammifères. Les ARN circulaires ont suscité un grand intérêt en raison de leur potentielle implication dans les maladies liées à l'âge. Financé par le programme Actions Marie Skłodowska-Curie, le projet circRTrain entend étudier la biogenèse et la fonction des ARN circulaires, à appréhender le rôle qu’ils jouent dans les maladies et à explorer leur potentiel en tant que biomarqueurs. Les chercheurs combineront différentes technologies et systèmes modèles pour comprendre la pertinence médicale des ARN circulaires. Le projet formera également des chercheurs en début de carrière dans ce nouveau domaine prometteur.

Objectif

CircRTrain focuses on circular RNAs (circRNAs), a new large class of single-stranded RNAs with covalently closed ends. CircRNAs have only very recently attracted high general interest and become the focus of an increasing number of publications: recent discoveries through sequencing technology and computational analyses have revealed the widespread existence of circRNAs in animal cells. Particularly in neural tissues, circRNA expression is high, dynamic, and evolutionarily conserved. In aging animal brains the expression of certain circRNAs is strongly elevated, suggesting connections to age-related diseases. The study of circRNAs thus emerges as a novel topic with highest importance for the understanding of such diverse conditions as neurodegenerative diseases, aging, and cancer. Moreover, the highly stable expression and their presence in human blood and exosomes make circRNAs attractive biomarker candidates.
The overall aims of circRTrain are to 1. Elucidate the biogenesis and function of circRNAs; 2. Define their role in diseases; 3. Exploit their potential as biomarkers and for medical applications; and 4. Combine cutting-edge technologies and disciplines.
Understanding circRNAs and exploring their medical relevance requires to integrate various technologies (sequencing, single-molecule and whole-organism imaging, RNA knockdown/delivery, CRISPR/CAS9), disciplines (biochemistry, computational biology, genetics), model systems (worm, fly, mouse, human) and medical applications (biomarkers, new therapeutic strategies).
CircRTrain will combine these diverse approaches and industrial technologies by training 15 early stage researchers (ESR) at two SMEs and seven academic partners, which are all leaders in their respective fields. Additionally, cooperation with four partner organizations, circRNA devoted conferences, winter- and summer schools will extend training for the ESRs, sustaining the critical number of young talented professionals in the field.

Coordinateur

MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)
Contribution nette de l'UE
€ 996 865,92
Adresse
ROBERT ROSSLE STRASSE 10
13125 Berlin
Allemagne

Voir sur la carte

Région
Berlin Berlin Berlin
Type d’activité
Research Organisations
Liens
Coût total
€ 996 865,92

Participants (7)

Partenaires (4)